Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
BioProgress announces agreement with Uluru on Oradisc product in Europe, CIS, Middle East
January 29th, 2007
BioProgress plc (BPRG), a speciality pharma and healthcare company, announced that it has agreed to a new strategic partnership agreement with Uluru Inc, for the treatment of mouth ulcers using Uluru's Oradisc technology, in the European, CIS (Commonwealth of Independent States) and Middle Eastern markets. The product agreement is in addition to the current anti-emetic product already in development between the two parties. The product fits within BioProgress' strategy of patient supportive care, especially painful conditions of the mouth such as those seen in patients undergoing oncology treatment. The product is expected to be available both as a...
Source: Biotech Business Week (2007-01-29)
|
